High-throughput sequencing of OS cells treated with activated compound B5.
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP278596
下载链接
链接失效反馈官方服务：
资源简介：
The high-throughput sequencing technology was performed after the treatment of human osteosarcoma cells U2OS and MG63 with the active compound B5 designed and synthesized by ourselves, to explore the expression of genes related to cell adhesion, migration and invasion of human osteosarcoma cells U2OS and MG63 after the treatment of the active compound Changes to explore the effect of active compounds on the motility of osteosarcoma cells. Overall design: Human osteosarcoma cells U2OS and MG63 was treated with active compound B5 at the concentration of 10µM for 48 hours.
创建时间：
2020-08-26
